Irinotecan Hydrochloride 20mg/ml Concentrate for Solution for Infusion (15ml vial) Malta - English - Medicines Authority

irinotecan hydrochloride 20mg/ml concentrate for solution for infusion (15ml vial)

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents

Irinotecan Hydrochloride 20mg/ml Concentrate for Solution for Infusion (25ml vial) Malta - English - Medicines Authority

irinotecan hydrochloride 20mg/ml concentrate for solution for infusion (25ml vial)

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents

Irinotecan Hydrochloride 20 mg/ml Concentrate for Solution for Infusion (50ml vial) Malta - English - Medicines Authority

irinotecan hydrochloride 20 mg/ml concentrate for solution for infusion (50ml vial)

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents

CAMPTOSAR irinotecan hydrochloride trihydrate 300mg/15mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

camptosar irinotecan hydrochloride trihydrate 300mg/15ml injection vial

pfizer australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: sorbitol; hydrochloric acid; water for injections; sodium hydroxide; lactic acid - camptosar is indicated as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum and is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Irinotecan Accord New Zealand - English - Medsafe (Medicines Safety Authority)

irinotecan accord

pharmacy retailing (nz) ltd t/a healthcare logistics - irinotecan hydrochloride trihydrate 20 mg/ml ((equivalent to 17.33 mg irinotecan));   - solution for infusion - 20 mg/ml - active: irinotecan hydrochloride trihydrate 20 mg/ml ((equivalent to 17.33 mg irinotecan))   excipient: hydrochloric acid lactic acid sodium hydroxide sorbitol water for injection - irinotecan hydrochloride trihydrate injection is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum, in combination with 5fu/leucovorin. irinotecan hydrochloride trihydrate injection is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Irinotecan Hydrochloride 20mg/ml concentrate for solution for infusion (100mg/5ml) Malta - English - Medicines Authority

irinotecan hydrochloride 20mg/ml concentrate for solution for infusion (100mg/5ml)

hospira uk limited - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg - antineoplastic agents

Irinotecan Hydrochloride 20mg/ml concentrate for solution for infusion (500mg/25ml) Malta - English - Medicines Authority

irinotecan hydrochloride 20mg/ml concentrate for solution for infusion (500mg/25ml)

hospira uk limited - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg - antineoplastic agents

Irinotecan Hydrochloride Concentrate for Soln for Inf 20mg/ml (5ml vial) Malta - English - Medicines Authority

irinotecan hydrochloride concentrate for soln for inf 20mg/ml (5ml vial)

accord healthcare limited - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents

Irinotecan Hydrochloride Concentrate for Soln for Inf 20mg/ml (15ml vial) Malta - English - Medicines Authority

irinotecan hydrochloride concentrate for soln for inf 20mg/ml (15ml vial)

accord healthcare limited - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents

Irinotecan Hydrochloride Concentrate for Soln for Inf 20mg/ml (25ml vial) Malta - English - Medicines Authority

irinotecan hydrochloride concentrate for soln for inf 20mg/ml (25ml vial)

accord healthcare limited - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents